Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 77

    1.

    Adaptive Cerebral Neovascularization in a Model of Type 2 Diabetes: Relevance to Focal Cerebral Ischemia.

    Li W, Prakash R, Kelly-Cobbs AI, Ogbi S, Kozak A, El-Remessy AB, Schreihofer DA, Fagan SC, Ergul A.

    Diabetes. 2009 Oct 6. [Epub ahead of print]PMID: 19808897 [PubMed - as supplied by publisher]Related articles

    2.

    Genetic characterization of green bean (Phaseolus vulgaris) genotypes from eastern Turkey.

    Sarikamiş G, Yaşar F, Bakir M, Kazan K, Ergül A.

    Genet Mol Res. 2009 Jul 28;8(3):880-7.PMID: 19731210 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.

    Machado LS, Sazonova IY, Kozak A, Wiley DC, El-Remessy AB, Ergul A, Hess DC, Waller JL, Fagan SC.

    Stroke. 2009 Sep;40(9):3028-33. Epub 2009 Jul 23.PMID: 19628804 [PubMed - indexed for MEDLINE]Related articles

    4.

    Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats.

    Elewa HF, Kozak A, El-Remessy AB, Frye RF, Johnson MH, Ergul A, Fagan SC.

    J Pharmacol Exp Ther. 2009 Aug;330(2):532-40. Epub 2009 May 28.PMID: 19478137 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke.

    Deutsch C, Portik-Dobos V, Smith AD, Ergul A, Dorrance AM.

    Microvasc Res. 2009 Jun;78(1):100-6. Epub 2009 Apr 15.PMID: 19374911 [PubMed - indexed for MEDLINE]Related articles

    6.

    Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.

    Kozak A, Ergul A, El-Remessy AB, Johnson MH, Machado LS, Elewa HF, Abdelsaid M, Wiley DC, Fagan SC.

    Stroke. 2009 May;40(5):1870-6. Epub 2009 Mar 5.PMID: 19265050 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature.

    Ergul A, Li W, Elgebaly MM, Bruno A, Fagan SC.

    Vascul Pharmacol. 2009 Jul;51(1):44-9. Epub 2009 Mar 1.PMID: 19258053 [PubMed - in process]Related articles

    8.

    Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

    Sachidanandam K, Hutchinson JR, Elgebaly MM, Mezzetti EM, Dorrance AM, Motamed K, Ergul A.

    Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R952-9. Epub 2009 Jan 28.PMID: 19176890 [PubMed - indexed for MEDLINE]Related articles

    9.

    Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway.

    Giachini FR, Zemse SM, Carneiro FS, Lima VV, Carneiro ZN, Callera GE, Ergul A, Webb RC, Tostes RC.

    Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H489-96. Epub 2008 Dec 12.PMID: 19074677 [PubMed - indexed for MEDLINE]Related articles

    10.

    Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes.

    Sachidanandam K, Hutchinson JR, Elgebaly MM, Mezzetti EM, Wang MH, Ergul A.

    J Pharmacol Exp Ther. 2009 Jan;328(1):123-30. Epub 2008 Oct 21.PMID: 18941121 [PubMed - indexed for MEDLINE]Related articles

    11.

    Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.

    Carneiro FS, Nunes KP, Giachini FR, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Clinton Webb R, Tostes RC.

    J Sex Med. 2008 Dec;5(12):2793-807. Epub 2008 Sep 24.PMID: 18823320 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1.

    Elgebaly MM, Kelly A, Harris AK, Elewa H, Portik-Dobos V, Ketsawatsomkron P, Marrero M, Ergul A.

    Can J Physiol Pharmacol. 2008 Jun;86(6):358-64.PMID: 18516099 [PubMed - indexed for MEDLINE]Related articles

    13.

    DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum.

    Carneiro FS, Giachini FR, Lima VV, Carneiro ZN, Nunes KP, Ergul A, Leite R, Tostes RC, Webb RC.

    Can J Physiol Pharmacol. 2008 Jun;86(6):320-8.PMID: 18516094 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

    Sachidanandam K, Elgebaly MM, Harris AK, Hutchinson JR, Mezzetti EM, Portik-Dobos V, Ergul A.

    Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2743-9. Epub 2008 Apr 18.PMID: 18424628 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

    Harris AK, Elgebaly MM, Li W, Sachidanandam K, Ergul A.

    Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1213-9. Epub 2008 Feb 20.PMID: 18287215 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes.

    Ergul A, Elgebaly MM, Middlemore ML, Li W, Elewa H, Switzer JA, Hall C, Kozak A, Fagan SC.

    BMC Neurol. 2007 Oct 15;7:33.PMID: 17937795 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes.

    Sachidanandam K, Portik-Dobos V, Harris AK, Hutchinson JR, Muller E, Johnson MH, Ergul A.

    Diabetes. 2007 Nov;56(11):2753-8. Epub 2007 Aug 1.PMID: 17670915 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes.

    Elgebaly MM, Portik-Dobos V, Sachidanandam K, Rychly D, Malcom D, Johnson MH, Ergul A.

    Vascul Pharmacol. 2007 Aug-Sep;47(2-3):125-30. Epub 2007 Jun 6.PMID: 17597010 [PubMed - indexed for MEDLINE]Related articles

    19.

    Transcript abundance profiles reveal larger and more complex responses of grapevine to chilling compared to osmotic and salinity stress.

    Tattersall EA, Grimplet J, DeLuc L, Wheatley MD, Vincent D, Osborne C, Ergül A, Lomen E, Blank RR, Schlauch KA, Cushman JC, Cramer GR.

    Funct Integr Genomics. 2007 Oct;7(4):317-33. Epub 2007 Jun 20.PMID: 17578611 [PubMed - indexed for MEDLINE]Related articles

    20.

    Proteomic analysis reveals differences between Vitis vinifera L. cv. Chardonnay and cv. Cabernet Sauvignon and their responses to water deficit and salinity.

    Vincent D, Ergül A, Bohlman MC, Tattersall EA, Tillett RL, Wheatley MD, Woolsey R, Quilici DR, Joets J, Schlauch K, Schooley DA, Cushman JC, Cramer GR.

    J Exp Bot. 2007;58(7):1873-92. Epub 2007 Apr 18.PMID: 17443017 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection.

    Elewa HF, Kozak A, Johnson MH, Ergul A, Fagan SC.

    J Hypertens. 2007 Apr;25(4):855-9.PMID: 17351379 [PubMed - indexed for MEDLINE]Related articles

    22.

    Water and salinity stress in grapevines: early and late changes in transcript and metabolite profiles.

    Cramer GR, Ergül A, Grimplet J, Tillett RL, Tattersall EA, Bohlman MC, Vincent D, Sonderegger J, Evans J, Osborne C, Quilici D, Schlauch KA, Schooley DA, Cushman JC.

    Funct Integr Genomics. 2007 Apr;7(2):111-34. Epub 2006 Nov 29.PMID: 17136344 [PubMed - indexed for MEDLINE]Related articles

    23.

    Multiple origins of cultivated grapevine (Vitis vinifera L. ssp. sativa) based on chloroplast DNA polymorphisms.

    Arroyo-García R, Ruiz-García L, Bolling L, Ocete R, López MA, Arnold C, Ergul A, Söylemezoğlu G, Uzun HI, Cabello F, Ibáñez J, Aradhya MK, Atanassov A, Atanassov I, Balint S, Cenis JL, Costantini L, Goris-Lavets S, Grando MS, Klein BY, McGovern PE, Merdinoglu D, Pejic I, Pelsy F, Primikirios N, Risovannaya V, Roubelakis-Angelakis KA, Snoussi H, Sotiri P, Tamhankar S, This P, Troshin L, Malpica JM, Lefort F, Martinez-Zapater JM.

    Mol Ecol. 2006 Oct;15(12):3707-14.PMID: 17032268 [PubMed - indexed for MEDLINE]Related articles

    24.

    Elevated endothelin-1 levels are associated with decreased arterial elasticity in hypertensive patients.

    Ergul A, Jupin D, Johnson MH, Prisant LM.

    J Clin Hypertens (Greenwich). 2006 Aug;8(8):549-54.PMID: 16896270 [PubMed - indexed for MEDLINE]Related articles

    25.

    Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.

    Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC.

    BMC Neurosci. 2006 Jul 17;7:56.PMID: 16846501 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    AFLP analysis of genetic variation within the two economically important Anatolian grapevine (Vitis vinifera L.) varietal groups.

    Ergül A, Kazan K, Aras S, Cevik V, Celik H, Söylemezoğlu G.

    Genome. 2006 May;49(5):467-75.PMID: 16767171 [PubMed - indexed for MEDLINE]Related articles

    27.

    Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1.

    Sachidanandam K, Harris A, Hutchinson J, Ergul A.

    Exp Biol Med (Maywood). 2006 Jun;231(6):1016-21.PMID: 16741041 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Phosphorylation of endothelin converting enzyme-1 isoforms: relevance to subcellular localization.

    Jafri F, Ergul A.

    Exp Biol Med (Maywood). 2006 Jun;231(6):713-7.PMID: 16740986 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size.

    Song W, Ergul A.

    Cardiovasc Diabetol. 2006 Feb 17;5:3.PMID: 16503991 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection.

    Fagan SC, Kozak A, Hill WD, Pollock DM, Xu L, Johnson MH, Ergul A, Hess DC.

    J Hypertens. 2006 Mar;24(3):535-9.PMID: 16467657 [PubMed - indexed for MEDLINE]Related articles

    31.

    Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis.

    Verdi H, Koytak ES, Onder O, Ergül AA, Cinar K, Idilman R, Erden E, Bozdayi AM, Yurdaydin C, Uzunalimoglu O, Bozkaya H.

    J Investig Med. 2005 Nov;53(7):353-9.PMID: 16297361 [PubMed - indexed for MEDLINE]Related articles

    32.

    Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.

    Portik-Dobos V, Harris AK, Song W, Hutchinson J, Johnson MH, Imig JD, Pollock DM, Ergul A.

    Am J Physiol Regul Integr Comp Physiol. 2006 Feb;290(2):R435-41. Epub 2005 Oct 20.PMID: 16239374 [PubMed - indexed for MEDLINE]Related articles

    33.

    Characterizing the grape transcriptome. Analysis of expressed sequence tags from multiple Vitis species and development of a compendium of gene expression during berry development.

    da Silva FG, Iandolino A, Al-Kayal F, Bohlmann MC, Cushman MA, Lim H, Ergul A, Figueroa R, Kabuloglu EK, Osborne C, Rowe J, Tattersall E, Leslie A, Xu J, Baek J, Cramer GR, Cushman JC, Cook DR.

    Plant Physiol. 2005 Oct;139(2):574-97.PMID: 16219919 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1.

    Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, Ergul A.

    Diabetes. 2005 Sep;54(9):2638-44.PMID: 16123352 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke.

    Harris AK, Ergul A, Kozak A, Machado LS, Johnson MH, Fagan SC.

    BMC Neurosci. 2005 Aug 3;6:49.PMID: 16078993 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Oxidative stress and cardiovascular disease: antioxidants and unresolved issues.

    Sachidanandam K, Fagan SC, Ergul A.

    Cardiovasc Drug Rev. 2005 Summer;23(2):115-32. Review.PMID: 16007229 [PubMed - indexed for MEDLINE]Related articles

    37.

    Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.

    Johansen JS, Harris AK, Rychly DJ, Ergul A.

    Cardiovasc Diabetol. 2005 Apr 29;4(1):5. Review.PMID: 15862133 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Tactics for vascular protection after acute ischemic stroke.

    Fagan SC, Hess DC, Machado LS, Hohnadel EJ, Pollock DM, Ergul A.

    Pharmacotherapy. 2005 Mar;25(3):387-95. Review.PMID: 15843286 [PubMed - indexed for MEDLINE]Related articles

    39.

    Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1.

    Ergul A, Johansen JS, Strømhaug C, Harris AK, Hutchinson J, Tawfik A, Rahimi A, Rhim E, Wells B, Caldwell RW, Anstadt MP.

    J Pharmacol Exp Ther. 2005 Apr;313(1):70-7. Epub 2004 Dec 17.PMID: 15608082 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.

    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.

    Am J Hypertens. 2004 Sep;17(9):775-82.PMID: 15363819 [PubMed - indexed for MEDLINE]Related articles

    41.

    Targets for vascular protection after acute ischemic stroke.

    Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A.

    Stroke. 2004 Sep;35(9):2220-5. Epub 2004 Jul 29. Review.PMID: 15284446 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction.

    Ergul S, Brunson CY, Hutchinson J, Tawfik A, Kutlar A, Webb RC, Ergul A.

    Am J Hematol. 2004 Jul;76(3):245-51.PMID: 15224360 [PubMed - indexed for MEDLINE]Related articles

    43.

    Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits.

    Anstadt MP, Franga DL, Portik-Dobos V, Pennathur A, Bannan M, Mawulawde K, Ergul A.

    Chest. 2004 May;125(5):1853-8.PMID: 15136400 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension.

    Mitchell BM, Dorrance AM, Ergul A, Webb RC.

    J Cardiovasc Pharmacol. 2004 Jan;43(1):93-8.PMID: 14668573 [PubMed - indexed for MEDLINE]Related articles

    45.

    Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke.

    Mehta SH, Webb RC, Ergul A, Tawfik A, Dorrance AM.

    Am J Physiol Regul Integr Comp Physiol. 2004 Feb;286(2):R283-8. Epub 2003 Oct 30. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2004 Apr;286(4):R801. Tawak Amany [corrected to Tawfik Amany]. PMID: 14592931 [PubMed - indexed for MEDLINE]Related articles

    46.

    Nuclear localization of endothelin-converting enzyme-1: subisoform specificity.

    Jafri F, Ergul A.

    Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2192-6. Epub 2003 Oct 9.PMID: 14551152 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation.

    Ergul A, Portik-Dobos V, Giulumian AD, Molero MM, Fuchs LC.

    Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H2225-32. Epub 2003 Jul 3.PMID: 12842810 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Decreased vascular matrix metalloproteinase abundance in diabetic patients with symptomatic macroangiopathy.

    Mondy JS, Anstadt MP, Franga DL, Portik-Dobos V, Hutchinson J, Ergul A.

    Ethn Dis. 2002 Fall;12(4):S3-18-22.PMID: 12477149 [PubMed - indexed for MEDLINE]Related articles

    49.

    Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes.

    Anstadt MP, Hutchinson J, Portik-Dobos V, Jafri F, Bannan M, Mawulawde K, Ergul A.

    Ethn Dis. 2002 Fall;12(4):S3-5-9.PMID: 12477147 [PubMed - indexed for MEDLINE]Related articles

    50.

    Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes.

    Portik-Dobos V, Anstadt MP, Hutchinson J, Bannan M, Ergul A.

    Diabetes. 2002 Oct;51(10):3063-8.PMID: 12351448 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...